Abstract:The in vitro dissolution mechanism of an amorphous solid dispersion (ASD) remains elusive and highly individualized, yet rational design of ASDs with optimal performance and prediction of their in vitro/in vivo performance are very much desirable in the pharmaceutical industry. To this end, we carried out comprehensive investigation of various ASD systems of griseofulvin, felodipine, and ketoconazole, in PVP-VA or HPMC-AS at different drug loading. Physiochemical properties and processes related to drug-polymer-water interaction, including the drug crystallization tendency in aqueous medium, drug-polymer interaction before and after moisture exposure, supersaturation of drug in the presence of polymer, polymer dissolution kinetics, etc., were characterized and correlated with the dissolution performance of ASDs at different dose and different drug/polymer ratio. It was observed that ketoconazole/HPMC-AS ASD outperformed all other ASDs in various dissolution conditions, which was attributed to the drugs low crystallization tendency, the strong ketoconazole/HPMC-AS interaction and the robustness of this interaction against water disruption, the dissolution rate and the availability of HPMC-AS in solution, and the ability of HPMC-AS in maintaining ketoconazole supersaturation. It was demonstrated that all these properties have implications for the dissolution performance of various ASD systems, and further quantification of them could be used as potential predictors for in vitro dissolution of ASDs. For all ASDs investigated, HPMC-AS systems performed better than, or at least comparably with, their PVP-VA counterparts, regardless of the drug loading or dose. This observation cannot be solely attributed to the ability of HPMC-AS in maintaining drug supersaturation. We also conclude that, for fast crystallizers without strong drug-polymer interaction, the only feasible option to improve dissolution might be to lower the dose and the drug loading in the ASD. In this study, we implemented an ASD/water Flory-Huggins parameter plot, which might assist in revealing the physical nature of the drug-polymer interaction. We also introduced supersaturation parameter and dissolution performance parameter as two quantitative measurements to compare the abilities of polymers in maintaining drug supersaturation, and the dissolution performance of various solid dispersions, respectively.

In Vitro Dissolution and Physicochemical Characterizations of Novel PVP-based Solid Dispersions Containing Valsartan Prepared by a Freeze-Drying Method.

Enhanced Dissolution and Oral Bioavailability of Valsartan Solid Dispersions Prepared by a Freeze-Drying Technique Using Hydrophilic Polymers

In-Vitro Characterization And Oral Bioavailability Of Organic Solvent-Free Solid Dispersions Containing Telmisartan

Preparation and Dissolution of Polyvinylpyrrolidone(PVP)-Based Solid Dispersion Systems Containing Solubilizers

Study of a Novel Disintegrable Oleanolic Acid-Polyvinylpolypyrrolidone Solid Dispersion

pH-independent controlled release tablets containing nanonizing valsartan solid dispersions for less variable bioavailability in humans

Enhanced Oral Bioavailability of Novel Mucoadhesive Pellets Containing Valsartan Prepared by a Dry Powder-Coating Technique.

Preparation and evaluation of valsartan by a novel semi-solid self-microemulsifying delivery system using Gelucire 44/14

Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles

Studies on Preparation of Candesartan Solid Dispersion and Its Dissolution and Stability

Enhancement of dissolution profile by solid dispersion (kneading) technique

Amino Acids As Co-Amorphous Excipients for Tackling the Poor Aqueous Solubility of Valsartan.

Evaluate the Ability of PVP to Inhibit Crystallization of Amorphous Solid Dispersions by Density Functional Theory and Experimental Verify.

Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies

In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.

Facile preparation of solid dispersions by dissolving drugs in <i>N</i>-vinyl-2-pyrrolidone and photopolymerization

Carrier particle mediated stabilization and isolation of valsartan nanoparticles

Valsartan/2-Aminopyridine Co-Amorphous System: Preparation, Characterization, and Supramolecular Structure Simulation by Density Functional Theory Calculation

Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.

Preparation and Dissolution of Compound Valsartan and Amlodipine Besylate Tablets

Enhancement of Dissolution Rate of Valdecoxib Using Solid Dispersions with Polyethylene Glycol 4000